Chemotherapy Regimens and Survival in Pancreatic Cancer—A Ten‐Year Single Centre Overview
Since 2010 there has been a shift in chemotherapy treatment for pancreatic cancer patients towards the use of combination therapies. Our data demonstrates an increase in 2-year survival for resected patients, whereas corresponding figures for the palliative patients remain unchanged.
Authors
- Caroline Williamsson (ORCID: https://orcid.org/0000-0002-9743-3149)
- Hanna Sternby (ORCID: https://orcid.org/0000-0002-4689-7154)
- F. Brandt
- Hedda Tranvik
Institutions
- Uppsala University Hospital (SE)
- Lund University (SE)
- Skåne University Hospital (SE)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/cam4.71416
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00